Document Detail

Comparison of a new recirculation thrombectomy catheter with other devices of the same type: in vitro and in vivo evaluations.
MedLine Citation:
PMID:  12218446     Owner:  NLM     Status:  MEDLINE    
RATIONALE AND OBJECTIVES: To compare a new 7 Fr. Helix thrombectomy catheter with Amplatz thrombectomy devices (ATD) with respect to clot fragmentation efficiency, hemolytic potential, and risk for vascular trauma. MATERIALS AND METHODS: Particle size was evaluated following the maceration of 8-to-10-day-old clots, each weighing 6 +/- 0.01 g. The clots were macerated using devices of various sizes, including the 7-Fr. Helix thrombectomy catheter, the 7-Fr. over-the-wire (OTW), 8-Fr. ATD and the 6-Fr. ATD. The number of particles by weight was quantified. The 7-Fr. Helix and the 8-Fr. ATD were tested in the native iliac vein of six dogs without presence of clots. Blood samples were obtained before, during, and at 1, 3, 6, 24, and 48 hours after the procedure, to monitor the hemolytic effects. The treated iliac veins were examined histologically. RESULTS: Most of the clot was fragmented into particles <10 microm. The mean percentage by weight of the original clot that remained as particles larger than 10 microm was 1.59% in the 7-Fr. Helix group. This was significantly less than 3.10% with the 6-Fr. ATD, 2.57% with 7-Fr. OTW and 2.44% in the 8-Fr. ATD group (<0.01). In vivo results showed a higher plasma free hemoglobin (PFH) level starting 5 minutes after initiating the ATD activation, reaching its peak after completion of the activation, and declining afterward, with return to the baseline at 24 hours. The haptoglobin level tended to decline slightly at 10 minutes, reaching its lowest level at 24 hours, and starting to recover at 48 hours. A similar pattern of PFH and haptoglobin changes was found in both groups. There were no significant differences regarding hemolytic effect of the two tested devices. No significant changes of creatinine were observed for up to 48 hours after procedures. Focal microthrombosis was seen in two sites of two vessels treated with the 7-Fr. Helix and a focal injury of a venous valve was noted in the 8-Fr. ATD group. The media and internal elastic lamina (IEL) were intact in all cases. CONCLUSION: The newly designed 7-Fr. Helix is more effective in fragmentation in vitro clots than the 6 Fr. ATD, 7-Fr. OTW and the 8-Fr. ATD. The 7-Fr. Helix and the 8-Fr. ATD produced hemolytic effects, but they appeared to be tolerated by the animals. The in vivo results indicated that the 7-Fr. Helix appears to be as safe as the 8-Fr. ATD.
Zhong Qian; Peter Kvamme; Dina Raghed; Manuel Maynar; John Hamide; William D Scheer; Carmen Espinoza; Beatriz Loscertales; Wilfrido R Castañeda
Related Documents :
18328956 - Evaluation of an immunochemotherapeutic protocol constituted of n-methyl meglumine anti...
14710876 - Duration of serologic response to five viral antigens in dogs.
8524916 - Population dynamics, intervention and survival in african wild dogs (lycaon pictus).
1474656 - Diseases and parasites of red foxes, gray foxes, and coyotes from commercial sources se...
20117266 - Functional characterization of in vivo effector cd4(+) and cd8(+) t cell responses in a...
15319086 - Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Investigative radiology     Volume:  37     ISSN:  0020-9996     ISO Abbreviation:  Invest Radiol     Publication Date:  2002 Sep 
Date Detail:
Created Date:  2002-09-09     Completed Date:  2002-10-30     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0045377     Medline TA:  Invest Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  503-11     Citation Subset:  IM    
Department of Radiology, Louisiana State University Health Sciences Center, New Orleans 70112, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Equipment Design
Evaluation Studies as Topic
Haptoglobins / analysis
Hemoglobins / analysis
Thrombectomy / instrumentation*
Thrombosis / pathology,  therapy*
Reg. No./Substance:
0/Haptoglobins; 0/Hemoglobins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Variation of the coronary calcium score depending on image reconstruction interval and scoring algor...
Next Document:  Capillary embolization using ethiodol-ethanol for complete renal ablation in Swine.